Cargando…

Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Zhao, Yingjun, Xu, Huaxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097049/ https://www.ncbi.nlm.nih.gov/pubmed/35550609 http://dx.doi.org/10.1186/s13024-022-00541-z

Ejemplares similares

EphB2: potential therapeutic target for Alzheimer’s disease
Publicado: (2011)

NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease
por: Zhang, Yun, et al.
Publicado: (2020)

Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
por: Nizami, Sohaib, et al.
Publicado: (2019)

Alzheimer’s disease: targeting the peripheral circulation
por: Liu, Zhi-Hao, et al.
Publicado: (2023)

Lactate-avid regulatory T cells: metabolic plasticity controls immunosuppression in tumour microenvironment
por: Multhoff, Gabriele, et al.
Publicado: (2021)

Plasma pTau181 as a biomarker for Alzheimer's disease
por: Meng, Jie, et al.
Publicado: (2020)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Tainted air: The link between pollution and Alzheimer's disease
por: Walton, Emma Louise
Publicado: (2018)

For better or worse: Immune system involvement in Alzheimer's Disease
por: Walton, Emma L.
Publicado: (2018)

ASGR1: an emerging therapeutic target in hypercholesterolemia
por: Zhao, Wenqi, et al.
Publicado: (2023)

Metabolic interaction: tumor-derived lactate inhibiting CD8(+) T cell cytotoxicity in a novel route
por: Wang, Ke, et al.
Publicado: (2023)

Targeting metabolic/epigenetic pathways: a potential strategy for cancer therapy in diffuse intrinsic pontine gliomas
por: Zhao, Kun, et al.
Publicado: (2020)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
por: Weiskirchen, Ralf
Publicado: (2023)

Step further towards targeted senolytic therapy: therapeutic potential of uPAR-CAR T cells for senescence-related diseases
por: Huang, Yujia, et al.
Publicado: (2020)

Regulatory T cells as a therapeutic approach for inflammatory bowel disease
por: Laukova, Marcela, et al.
Publicado: (2023)

Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
por: Lepiarz-Raba, Izabela, et al.
Publicado: (2023)

Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease
por: Maezawa, Izumi, et al.
Publicado: (2012)

Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
por: Wolters-Eisfeld, Gerrit, et al.
Publicado: (2023)

Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease?
por: Bass, Britanny, et al.
Publicado: (2015)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site
por: Schwartz, Zander, et al.
Publicado: (2022)

Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
por: Jung, Eui-Man, et al.
Publicado: (2015)

The age factor in Alzheimer’s disease
por: Guerreiro, Rita, et al.
Publicado: (2015)

Identifying therapeutic targets for schizophrenia
por: Montague-Cardoso, Karli
Publicado: (2021)

Potential mechanisms by which impaired ketogenesis links metabolism to T‐cell dysfunction in patients with severe COVID‐19
por: Wang, Bin, et al.
Publicado: (2022)

Metabolic regulation of pyroptotic cell death expands the therapeutic landscape for treating inflammatory disease
por: Place, David E., et al.
Publicado: (2021)

Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer
por: Kurniawan, Henry, et al.
Publicado: (2020)

Mitochondrial dysfunction and alcohol-associated liver disease: a novel pathway and therapeutic target
por: Abdallah, Mohamed A., et al.
Publicado: (2020)

Targeting α7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injury
por: Shin, Samuel S., et al.
Publicado: (2015)

Opening the box of PANTHORA in Alzheimer’s disease
por: Korte, Martin, et al.
Publicado: (2022)

Brain insulin resistance in Alzheimer’s disease
Publicado: (2012)

Cyro-EM structure of human mGlus: leading therapeutic potential to neurological diseases
por: Xiao, Huan, et al.
Publicado: (2021)

Persistent astrocytic IL-3 stimulation of microglia slows disease in Alzheimer’s: treatment perspectives for Alzheimer’s
por: Haag, Natja, et al.
Publicado: (2021)

MicroRNAs circulate around Alzheimer's disease
por: Smith-Vikos, Thalyana, et al.
Publicado: (2013)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

Dynamic mechanism of GPCR-mediated β-arrestin: a potential therapeutic agent discovery of biased drug
por: Xu, Zheng, et al.
Publicado: (2022)

Human herpesvirus 4 and adaptive immunity in Alzheimer’s disease
por: Kang, Jian-Sheng, et al.
Publicado: (2020)

Trisomy 21–induced dysregulation of microglial homeostasis in Alzheimer’s brains is mediated by USP25
por: Zheng, Qiuyang, et al.
Publicado: (2021)

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
por: Xu, Yechun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8i5cnnvkk8mst0jlomf8nvej37